Auden Mckenzie, Allergan, other drugmakers lose appeals of UK hydrocortisone rulings
By Simon Zekaria ( July 28, 2026, 12:14 GMT | Insight) -- Drugmakers including Auden Mckenzie and Allergan have lost their appeals against a set of rulings by the UK's antitrust court that upheld regulatory findings of competition-law breaches over supply of hydrocortisone tablets. But the Court of Appeal said challenges over the level of penalties imposed on the drugmakers should be remitted to the Competition Appeal Tribunal for review as they had not been thoroughly examined.Drugmakers including Auden Mckenzie and Allergan have lost their appeals against a set of rulings by the UK's antitrust court that upheld regulatory findings of competition-law breaches over supply of hydrocortisone tablets....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.